Gulfcoast Oncology Associates is a clinical research site located in St. Petersburg, Florida, United States 33705.
Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.
Gulfcoast Oncology Associates has participated in 13 clinical trials.
Therapeutic areas: Follicular Lymphoma, Lymphoma, Follicular, Breast Cancer.
Sponsors: Spectrum Pharmaceuticals, Inc, Novartis Pharmaceuticals, SCRI Development Innovations, LLC.
Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Gulfcoast Oncology Associates has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Gulfcoast Oncology Associates has 13 clinical trials on record. Their work covers Follicular Lymphoma, Lymphoma, Follicular, Breast Cancer.
Yes — Gulfcoast Oncology Associates holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.